Premarket
Monday's Small Caps: INO Has FDA Approval, PERI Has a Cash Deal, CLRO Has Questions
INO surges after accelerated approval, PERI trades below its $11.70 cash agreement, and CLRO draws heavy volume without a verified fresh catalyst. A source-linked small-cap brief for November 2.